Parkinson’s disease is on the rise. 5 expert tips to reduce your risk of developing it

Researchers are developing a greater understanding of Parkinson’s disease, the fastest growing neurodegenerative disease ...

Cracking the code of Parkinson's: How supercomputers are pointing to new treatments

More than 1 million Americans live with tremors, slowed movement and speech changes caused by Parkinson's disease—a ...
WUFT

Q&A with Diego Guarin, a UF researcher using AI to try to transform Parkinson’s care

Diego Guarin, a University of Florida researcher exploring how artificial intelligence can transform the way Parkinson’s ...

AC Immune Rises on Positive Interim Data for Parkinson's Treatment

AC Immune shares were higher after the pharmaceutical company reported positive interim results from a Phase 2 trial for a Parkinson's disease treatment. Shares were up 13% to $3.14 in Thursday ...
Andrew Huberman on MSN

How to treat Alzheimer's & Parkinson's diseases

Exclusive: Watch a Coast Guard helicopter sniper disable a go-fast drug vessel in interdiction op Epidemiologist's harsh ...
News-Medical.Net on MSN

Van Andel Institute and Cure Parkinson's extend major Parkinson's drug trial initiative

Van Andel Institute and Cure Parkinson's have renewed a funding agreement to support the International Linked Clinical Trials ...

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

As per previous communication, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had informed Anavex about a negative trend-vote following its oral examination in ...